Psyence Biomedical Earnings Per Share vs. Current Valuation
| PBM Stock | USD 3.46 0.05 1.42% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 4.9 | 4.6625 |
|
|
For Psyence Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Psyence Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Psyence Biomedical Ltd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Psyence Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Psyence Biomedical Ltd over time as well as its relative position and ranking within its peers.
Psyence |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Psyence Biomedical Current Valuation vs. Earnings Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Psyence Biomedical's current stock value. Our valuation model uses many indicators to compare Psyence Biomedical value to that of its competitors to determine the firm's financial worth. Psyence Biomedical Ltd is considered to be number one stock in earnings per share category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Psyence Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Psyence Current Valuation vs. Earnings Per Share
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Psyence Biomedical |
| = | (7.82) X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Psyence Biomedical |
| = | 12.32 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Psyence Current Valuation vs Competition
Psyence Biomedical Ltd is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 2.97 Billion. Psyence Biomedical adds roughly 12.32 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Psyence Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Psyence Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Psyence Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Psyence Biomedical's change in net profit over the period of time. It can combine multiple indicators of Psyence Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 325 K | 288.8 K | |
| Net Interest Income | -50.8 K | -48.3 K | |
| Interest Income | 2.1 K | 1.4 K | |
| Operating Income | -2.8 M | -2.6 M | |
| Net Loss | -51.2 M | -48.6 M | |
| Income Before Tax | -51.2 M | -48.6 M | |
| Total Other Income Expense Net | -48.4 M | -46 M | |
| Net Loss | -51.2 M | -48.6 M | |
| Net Loss | (7.85) | (7.46) | |
| Income Quality | 0.06 | 0.06 |
Psyence Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Psyence Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Psyence Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Psyence Biomedical's important profitability drivers and their relationship over time.
Use Psyence Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Psyence Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will appreciate offsetting losses from the drop in the long position's value.Psyence Biomedical Pair Trading
Psyence Biomedical Ltd Pair Trading Analysis
The ability to find closely correlated positions to Psyence Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Psyence Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Psyence Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Psyence Biomedical Ltd to buy it.
The correlation of Psyence Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Psyence Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Psyence Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Psyence Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Psyence Biomedical position
In addition to having Psyence Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
To fully project Psyence Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Psyence Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Psyence Biomedical's income statement, its balance sheet, and the statement of cash flows.